Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024

SELL
$51.07 - $68.26 $5.11 Million - $6.83 Million
-100,000 Reduced 37.04%
170,000 $10.6 Million
Q4 2023

Feb 14, 2024

BUY
$55.6 - $77.89 $15 Million - $21 Million
270,000 New
270,000 $16.7 Million
Q2 2022

Aug 12, 2022

BUY
$55.54 - $72.65 $5.55 Million - $7.27 Million
100,000 New
100,000 $6.6 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $6.15B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.